DocuSign Beats Q2 Estimates, Guides Higher
DocuSign (NASDAQ: DOCU) reported fiscal Q2 2027 results on Thursday, September 3, 2026, after market close, posting revenue of $750 million, up 14% year-over-year and beating analyst expectations of $735 million. Adjusted earnings per share came in at $0.82, surpassing the consensus estimate of $0.76. The company also raised its full-year revenue guidance to $3.1 billion, citing strong adoption of its new AI-powered contract management tools.
Shares surged 12% in after-hours trading, reflecting investor relief after a volatile summer. The stock had fallen 18% since June on fears of slowing growth, but this quarter’s results, including a 20% increase in subscription revenue to $710 million, appear to have alleviated those concerns.
Why AI Features Are Driving Renewal Rates
DocuSign’s turnaround strategy hinges on integrating AI across its e-signature and contract lifecycle management (CLM) offerings. The company reported that customers using its AI-powered contract analysis tools, launched in early 2026, have a 92% renewal rate compared to 85% for those on legacy plans. This has boosted net revenue retention to 115%, up from 108% last year.
During the earnings call, CFO James Smith noted that “AI-driven upsells now account for 30% of new annual recurring revenue,” underscoring the strategic importance of these features. This shift is critical as DocuSign faces intensifying competition from CRM giant Salesforce (NYSE: CRM), which has expanded its own e-signature capabilities.
Salesforce Battle Intensifies Over E-Signature Market
Salesforce’s aggressive push into e-signatures, through its Salesforce Sign product introduced in late 2025, has yet to dent DocuSign’s market position. DocuSign still controls 70% of the e-signature market, according to industry data, but analysts warn that Salesforce’s bundling strategy could pressure pricing in the coming quarters.
DocuSign’s billings growth of 12% year-over-year to $800 million indicates resilience, but the company’s forward-looking guidance of $1.9 billion for Q3 revenue implies a slight deceleration. This suggests that while AI is helping, the competitive landscape remains a key risk.
Valuation Concerns That Could Derail the Rally
Despite the beat, DocuSign’s stock trades at 9.5 times forward revenue, a premium to its five-year average of 7 times. That valuation is justified only if the company can sustain double-digit growth, which may be challenging given macro headwinds and sign-up fatigue among SMBs.
Furthermore, operating cash flow grew just 8% to $200 million, lagging revenue growth. Some analysts argue that heavy investment in AI and international expansion will compress margins—operating margin fell to 18% from 20% last year—making the stock vulnerable to any guidance miss.
What to Watch: Q3 Earnings and AI Adoption Metrics
Investors should focus on DocuSign’s Q3 fiscal 2027 earnings report, expected in early December, for any signs of deceleration. Key metrics include the percentage of renewals involving AI features and whether net revenue retention can hold above 115%.
Also, watch for competitive commentary from Salesforce’s earnings call in late November. A major enterprise deal win by Salesforce could signal a shift in market dynamics, potentially breaking the bull case for DocuSign.
Comments are closed.